UniProt ID | CD2AP_HUMAN | |
---|---|---|
UniProt AC | Q9Y5K6 | |
Protein Name | CD2-associated protein | |
Gene Name | CD2AP | |
Organism | Homo sapiens (Human). | |
Sequence Length | 639 | |
Subcellular Localization | Cytoplasm, cytoskeleton . Cell projection, ruffle . Cell junction . Colocalizes with F-actin and BCAR1/p130Cas in membrane ruffles (PubMed:10339567). Located at podocyte slit diaphragm between podocyte foot processes (By similarity). During late anap | |
Protein Description | Seems to act as an adapter protein between membrane proteins and the actin cytoskeleton. [PubMed: 10339567 In collaboration with CBLC, modulates the rate of RET turnover and may act as regulatory checkpoint that limits the potency of GDNF on neuronal survival. Controls CBLC function, converting it from an inhibitor to a promoter of RET degradation (By similarity May play a role in receptor clustering and cytoskeletal polarity in the junction between T-cell and antigen-presenting cell (By similarity May anchor the podocyte slit diaphragm to the actin cytoskeleton in renal glomerolus. Also required for cytokinesis] | |
Protein Sequence | MVDYIVEYDYDAVHDDELTIRVGEIIRNVKKLQEEGWLEGELNGRRGMFPDNFVKEIKRETEFKDDSLPIKRERHGNVASLVQRISTYGLPAGGIQPHPQTKNIKKKTKKRQCKVLFEYIPQNEDELELKVGDIIDINEEVEEGWWSGTLNNKLGLFPSNFVKELEVTDDGETHEAQDDSETVLAGPTSPIPSLGNVSETASGSVTQPKKIRGIGFGDIFKEGSVKLRTRTSSSETEEKKPEKPLILQSLGPKTQSVEITKTDTEGKIKAKEYCRTLFAYEGTNEDELTFKEGEIIHLISKETGEAGWWRGELNGKEGVFPDNFAVQINELDKDFPKPKKPPPPAKAPAPKPELIAAEKKYFSLKPEEKDEKSTLEQKPSKPAAPQVPPKKPTPPTKASNLLRSSGTVYPKRPEKPVPPPPPIAKINGEVSSISSKFETEPVSKLKLDSEQLPLRPKSVDFDSLTVRTSKETDVVNFDDIASSENLLHLTANRPKMPGRRLPGRFNGGHSPTHSPEKILKLPKEEDSANLKPSELKKDTCYSPKPSVYLSTPSSASKANTTAFLTPLEIKAKVETDDVKKNSLDELRAQIIELLCIVEALKKDHGKELEKLRKDLEEEKTMRSNLEMEIEKLKKAVLSS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
15 | Ubiquitination | YDYDAVHDDELTIRV ECCCCCCCCCEEEEH | 44.47 | 24816145 | |
53 | Ubiquitination | RGMFPDNFVKEIKRE CCCCCHHHHHHHHHH | 12.38 | 21963094 | |
55 | Acetylation | MFPDNFVKEIKRETE CCCHHHHHHHHHHHC | 49.97 | 19813661 | |
58 | Sumoylation | DNFVKEIKRETEFKD HHHHHHHHHHHCCCC | 45.32 | - | |
58 | Sumoylation | DNFVKEIKRETEFKD HHHHHHHHHHHCCCC | 45.32 | 25218447 | |
64 | Ubiquitination | IKRETEFKDDSLPIK HHHHHCCCCCCCCCC | 55.16 | 24816145 | |
67 | Phosphorylation | ETEFKDDSLPIKRER HHCCCCCCCCCCHHH | 46.29 | 29514088 | |
71 | Ubiquitination | KDDSLPIKRERHGNV CCCCCCCCHHHCCCH | 46.39 | 29967540 | |
80 | Phosphorylation | ERHGNVASLVQRIST HHCCCHHHHHHHHHH | 25.45 | 22617229 | |
86 | Phosphorylation | ASLVQRISTYGLPAG HHHHHHHHHHCCCCC | 20.12 | 23401153 | |
87 | Phosphorylation | SLVQRISTYGLPAGG HHHHHHHHHCCCCCC | 21.16 | 30266825 | |
88 | Phosphorylation | LVQRISTYGLPAGGI HHHHHHHHCCCCCCC | 15.18 | 30266825 | |
101 | Phosphorylation | GIQPHPQTKNIKKKT CCCCCCCCCCCCHHC | 30.43 | 29978859 | |
102 | Ubiquitination | IQPHPQTKNIKKKTK CCCCCCCCCCCHHCC | 51.97 | 21963094 | |
119 | Phosphorylation | QCKVLFEYIPQNEDE HEEEEEEECCCCCCC | 15.57 | 20068231 | |
147 | Phosphorylation | EVEEGWWSGTLNNKL HHHCCCCCCCCCCCC | 18.52 | 26074081 | |
149 | Phosphorylation | EEGWWSGTLNNKLGL HCCCCCCCCCCCCCC | 22.31 | 26074081 | |
159 | Phosphorylation | NKLGLFPSNFVKELE CCCCCCCCCCEEEEE | 35.25 | 26074081 | |
168 | Phosphorylation | FVKELEVTDDGETHE CEEEEEECCCCCEEE | 20.99 | 30278072 | |
173 | Phosphorylation | EVTDDGETHEAQDDS EECCCCCEEEEECCC | 30.46 | 30576142 | |
180 | Phosphorylation | THEAQDDSETVLAGP EEEEECCCCEEECCC | 43.38 | 28176443 | |
182 | Phosphorylation | EAQDDSETVLAGPTS EEECCCCEEECCCCC | 25.44 | 29496963 | |
188 | Phosphorylation | ETVLAGPTSPIPSLG CEEECCCCCCCCCCC | 46.33 | 30278072 | |
189 | Phosphorylation | TVLAGPTSPIPSLGN EEECCCCCCCCCCCC | 24.78 | 30278072 | |
193 | Phosphorylation | GPTSPIPSLGNVSET CCCCCCCCCCCCCCC | 50.02 | 30576142 | |
198 | Phosphorylation | IPSLGNVSETASGSV CCCCCCCCCCCCCCC | 32.98 | 30278072 | |
200 | Phosphorylation | SLGNVSETASGSVTQ CCCCCCCCCCCCCCC | 20.72 | 28176443 | |
202 | Phosphorylation | GNVSETASGSVTQPK CCCCCCCCCCCCCCC | 38.73 | 28176443 | |
204 | Phosphorylation | VSETASGSVTQPKKI CCCCCCCCCCCCCEE | 21.35 | 28176443 | |
206 | Phosphorylation | ETASGSVTQPKKIRG CCCCCCCCCCCEECC | 40.63 | 28176443 | |
221 | 2-Hydroxyisobutyrylation | IGFGDIFKEGSVKLR CCCCHHHCCCEEEEE | 62.59 | - | |
221 | Ubiquitination | IGFGDIFKEGSVKLR CCCCHHHCCCEEEEE | 62.59 | 32015554 | |
224 | Phosphorylation | GDIFKEGSVKLRTRT CHHHCCCEEEEEECC | 19.71 | 23401153 | |
226 | Ubiquitination | IFKEGSVKLRTRTSS HHCCCEEEEEECCCC | 33.67 | - | |
229 | Phosphorylation | EGSVKLRTRTSSSET CCEEEEEECCCCCCC | 49.05 | 23927012 | |
231 | Phosphorylation | SVKLRTRTSSSETEE EEEEEECCCCCCCCC | 32.14 | 27273156 | |
232 | Phosphorylation | VKLRTRTSSSETEEK EEEEECCCCCCCCCC | 28.69 | 23927012 | |
233 | Phosphorylation | KLRTRTSSSETEEKK EEEECCCCCCCCCCC | 31.42 | 27273156 | |
234 | Phosphorylation | LRTRTSSSETEEKKP EEECCCCCCCCCCCC | 48.59 | 30278072 | |
236 | Phosphorylation | TRTSSSETEEKKPEK ECCCCCCCCCCCCCC | 51.93 | 30278072 | |
243 | Ubiquitination | TEEKKPEKPLILQSL CCCCCCCCCEEEHHC | 54.36 | 29967540 | |
249 | Phosphorylation | EKPLILQSLGPKTQS CCCEEEHHCCCCCCE | 31.67 | 23927012 | |
254 | Phosphorylation | LQSLGPKTQSVEITK EHHCCCCCCEEEEEE | 29.25 | 28450419 | |
256 | Phosphorylation | SLGPKTQSVEITKTD HCCCCCCEEEEEECC | 27.27 | 20164059 | |
260 | Phosphorylation | KTQSVEITKTDTEGK CCCEEEEEECCCCCC | 17.87 | 28450419 | |
262 | Phosphorylation | QSVEITKTDTEGKIK CEEEEEECCCCCCCC | 39.23 | 29978859 | |
264 | Phosphorylation | VEITKTDTEGKIKAK EEEEECCCCCCCCHH | 52.44 | 23312004 | |
316 | Ubiquitination | WRGELNGKEGVFPDN EEEEECCCCCCCCCC | 50.66 | 27667366 | |
333 | Ubiquitination | VQINELDKDFPKPKK EEHHHCCCCCCCCCC | 74.10 | 29967540 | |
359 | 2-Hydroxyisobutyrylation | PELIAAEKKYFSLKP HHHHEEEHHHHCCCH | 48.31 | - | |
359 | Acetylation | PELIAAEKKYFSLKP HHHHEEEHHHHCCCH | 48.31 | 25953088 | |
359 | Ubiquitination | PELIAAEKKYFSLKP HHHHEEEHHHHCCCH | 48.31 | 29967540 | |
360 | Acetylation | ELIAAEKKYFSLKPE HHHEEEHHHHCCCHH | 42.93 | 24471353 | |
361 | Phosphorylation | LIAAEKKYFSLKPEE HHEEEHHHHCCCHHH | 14.96 | 25159151 | |
361 | Ubiquitination | LIAAEKKYFSLKPEE HHEEEHHHHCCCHHH | 14.96 | 27667366 | |
363 | Phosphorylation | AAEKKYFSLKPEEKD EEEHHHHCCCHHHCC | 32.18 | 28152594 | |
365 | Ubiquitination | EKKYFSLKPEEKDEK EHHHHCCCHHHCCCC | 49.54 | 27667366 | |
369 | Ubiquitination | FSLKPEEKDEKSTLE HCCCHHHCCCCCCCC | 70.31 | 29967540 | |
380 | Phosphorylation | STLEQKPSKPAAPQV CCCCCCCCCCCCCCC | 59.30 | 25159151 | |
387 | Ubiquitination | SKPAAPQVPPKKPTP CCCCCCCCCCCCCCC | 9.49 | 21963094 | |
393 | Phosphorylation | QVPPKKPTPPTKASN CCCCCCCCCCCCHHH | 51.27 | 28985074 | |
396 | Phosphorylation | PKKPTPPTKASNLLR CCCCCCCCCHHHHHH | 40.21 | 29396449 | |
397 | Methylation | KKPTPPTKASNLLRS CCCCCCCCHHHHHHC | 56.44 | - | |
397 | Ubiquitination | KKPTPPTKASNLLRS CCCCCCCCHHHHHHC | 56.44 | 29967540 | |
399 | Phosphorylation | PTPPTKASNLLRSSG CCCCCCHHHHHHCCC | 29.57 | 28555341 | |
404 | Phosphorylation | KASNLLRSSGTVYPK CHHHHHHCCCCCCCC | 32.84 | 25159151 | |
405 | Phosphorylation | ASNLLRSSGTVYPKR HHHHHHCCCCCCCCC | 31.86 | 25159151 | |
407 | Phosphorylation | NLLRSSGTVYPKRPE HHHHCCCCCCCCCCC | 20.86 | 25159151 | |
409 | Phosphorylation | LRSSGTVYPKRPEKP HHCCCCCCCCCCCCC | 11.68 | 28152594 | |
415 | Ubiquitination | VYPKRPEKPVPPPPP CCCCCCCCCCCCCCC | 54.73 | 29967540 | |
425 | Acetylation | PPPPPIAKINGEVSS CCCCCCEEECCEEEC | 37.11 | 19828529 | |
431 | Phosphorylation | AKINGEVSSISSKFE EEECCEEECCCCCCC | 20.04 | 26437602 | |
432 | Phosphorylation | KINGEVSSISSKFET EECCEEECCCCCCCC | 31.50 | 26437602 | |
432 | Ubiquitination | KINGEVSSISSKFET EECCEEECCCCCCCC | 31.50 | 21963094 | |
434 | Phosphorylation | NGEVSSISSKFETEP CCEEECCCCCCCCCC | 29.44 | 21406692 | |
435 | Phosphorylation | GEVSSISSKFETEPV CEEECCCCCCCCCCC | 39.43 | 21406692 | |
436 | Acetylation | EVSSISSKFETEPVS EEECCCCCCCCCCCC | 40.19 | 26051181 | |
436 | Ubiquitination | EVSSISSKFETEPVS EEECCCCCCCCCCCC | 40.19 | 21963094 | |
439 | Phosphorylation | SISSKFETEPVSKLK CCCCCCCCCCCCCCC | 49.04 | 21406692 | |
443 | Phosphorylation | KFETEPVSKLKLDSE CCCCCCCCCCCCCHH | 42.88 | 21406692 | |
444 | Ubiquitination | FETEPVSKLKLDSEQ CCCCCCCCCCCCHHH | 50.29 | 29967540 | |
446 | Ubiquitination | TEPVSKLKLDSEQLP CCCCCCCCCCHHHCC | 54.72 | 29967540 | |
449 | Phosphorylation | VSKLKLDSEQLPLRP CCCCCCCHHHCCCCC | 37.36 | 23312004 | |
457 | Ubiquitination | EQLPLRPKSVDFDSL HHCCCCCCCCCCCCC | 57.59 | 29967540 | |
458 | Phosphorylation | QLPLRPKSVDFDSLT HCCCCCCCCCCCCCE | 29.60 | 19664994 | |
463 | O-linked_Glycosylation | PKSVDFDSLTVRTSK CCCCCCCCCEEECCC | 26.40 | 23301498 | |
463 | Phosphorylation | PKSVDFDSLTVRTSK CCCCCCCCCEEECCC | 26.40 | 22167270 | |
465 | Phosphorylation | SVDFDSLTVRTSKET CCCCCCCEEECCCCC | 16.34 | 23927012 | |
468 | Phosphorylation | FDSLTVRTSKETDVV CCCCEEECCCCCCCC | 39.55 | 22199227 | |
469 | Phosphorylation | DSLTVRTSKETDVVN CCCEEECCCCCCCCC | 20.24 | 22199227 | |
470 | Ubiquitination | SLTVRTSKETDVVNF CCEEECCCCCCCCCH | 65.11 | 29967540 | |
471 | Ubiquitination | LTVRTSKETDVVNFD CEEECCCCCCCCCHH | 50.43 | 21890473 | |
482 | Phosphorylation | VNFDDIASSENLLHL CCHHHCCCCCCCHHH | 38.22 | 28348404 | |
483 | Phosphorylation | NFDDIASSENLLHLT CHHHCCCCCCCHHHH | 22.83 | 28348404 | |
490 | Phosphorylation | SENLLHLTANRPKMP CCCCHHHHCCCCCCC | 15.90 | 27251275 | |
495 | Methylation | HLTANRPKMPGRRLP HHHCCCCCCCCCCCC | 55.26 | - | |
495 | Ubiquitination | HLTANRPKMPGRRLP HHHCCCCCCCCCCCC | 55.26 | 29967540 | |
510 | Phosphorylation | GRFNGGHSPTHSPEK CCCCCCCCCCCCHHH | 34.47 | 29255136 | |
512 | Phosphorylation | FNGGHSPTHSPEKIL CCCCCCCCCCHHHHH | 37.69 | 29255136 | |
514 | Phosphorylation | GGHSPTHSPEKILKL CCCCCCCCHHHHHCC | 36.91 | 29255136 | |
516 | Ubiquitination | HSPTHSPEKILKLPK CCCCCCHHHHHCCCH | 56.60 | 21890473 | |
520 | Ubiquitination | HSPEKILKLPKEEDS CCHHHHHCCCHHHCC | 67.24 | 21890473 | |
523 | Sumoylation | EKILKLPKEEDSANL HHHHCCCHHHCCCCC | 81.70 | 28112733 | |
523 | Ubiquitination | EKILKLPKEEDSANL HHHHCCCHHHCCCCC | 81.70 | 29967540 | |
539 | Phosphorylation | PSELKKDTCYSPKPS HHHHCCCCCCCCCCC | 23.40 | 30278072 | |
541 | Phosphorylation | ELKKDTCYSPKPSVY HHCCCCCCCCCCCEE | 30.05 | 30278072 | |
542 | Phosphorylation | LKKDTCYSPKPSVYL HCCCCCCCCCCCEEE | 28.70 | 30278072 | |
544 | Acetylation | KDTCYSPKPSVYLST CCCCCCCCCCEEEEC | 43.94 | 26051181 | |
544 | Ubiquitination | KDTCYSPKPSVYLST CCCCCCCCCCEEEEC | 43.94 | 29967540 | |
546 | Phosphorylation | TCYSPKPSVYLSTPS CCCCCCCCEEEECCC | 29.53 | 30278072 | |
548 | Phosphorylation | YSPKPSVYLSTPSSA CCCCCCEEEECCCCC | 10.16 | 25159151 | |
550 | Phosphorylation | PKPSVYLSTPSSASK CCCCEEEECCCCCCC | 22.15 | 25159151 | |
551 | Phosphorylation | KPSVYLSTPSSASKA CCCEEEECCCCCCCC | 25.29 | 25159151 | |
553 | Phosphorylation | SVYLSTPSSASKANT CEEEECCCCCCCCCC | 38.33 | 25159151 | |
554 | Phosphorylation | VYLSTPSSASKANTT EEEECCCCCCCCCCC | 37.45 | 25159151 | |
556 | Phosphorylation | LSTPSSASKANTTAF EECCCCCCCCCCCCE | 33.96 | 24260401 | |
557 | Ubiquitination | STPSSASKANTTAFL ECCCCCCCCCCCCEE | 45.43 | 29967540 | |
560 | Phosphorylation | SSASKANTTAFLTPL CCCCCCCCCCEECCE | 25.10 | 28450419 | |
561 | Phosphorylation | SASKANTTAFLTPLE CCCCCCCCCEECCEE | 18.41 | 28450419 | |
565 | Phosphorylation | ANTTAFLTPLEIKAK CCCCCEECCEEEEEE | 21.26 | 25159151 | |
570 | Ubiquitination | FLTPLEIKAKVETDD EECCEEEEEEECCCC | 32.55 | 32015554 | |
575 | Phosphorylation | EIKAKVETDDVKKNS EEEEEECCCCHHCCC | 40.25 | 28857561 | |
582 | Phosphorylation | TDDVKKNSLDELRAQ CCCHHCCCHHHHHHH | 46.18 | 23401153 | |
613 | Ubiquitination | KELEKLRKDLEEEKT HHHHHHHHHHHHHHH | 76.68 | 29967540 | |
623 | Phosphorylation | EEEKTMRSNLEMEIE HHHHHHHHHHHHHHH | 34.64 | 22210691 | |
627 | Sulfoxidation | TMRSNLEMEIEKLKK HHHHHHHHHHHHHHH | 7.67 | 21406390 | |
631 | Ubiquitination | NLEMEIEKLKKAVLS HHHHHHHHHHHHHHC | 71.86 | 29967540 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CD2AP_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CD2AP_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CD2AP_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
607832 | Focal segmental glomerulosclerosis 3 (FSGS3) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-458, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-224 AND SER-458, ANDMASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-458, AND MASSSPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-458, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-510, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-88, AND MASSSPECTROMETRY. |